Trials / Completed
CompletedNCT02148406
Programs to Support You During Chemotherapy (Pro-You)
Programs to Support You During Chemotherapy (Pro-You): Feasibility
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Vanderbilt-Ingram Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized pilot clinical trial studies Yoga Skills Training or attention control in reducing fatigue and depressive symptoms during chemotherapy in patients with stage II-IV colorectal cancer. Yoga Skills Training consists of meditation, movement and breathing practices that aim to promote mindfulness and relaxation. Attention control consists of conversations with a caring professional with a recommendation to complete daily home diaries. It is not yet known whether Yoga Skills Training is better than attention control at reducing fatigue and depressive symptoms in patients undergoing chemotherapy.The purpose of this initial feasibility study is to refine study procedures.
Detailed description
PRIMARY OBJECTIVES: I. To obtain preliminary data on the efficacy of the Yoga Skills Training (YST) for improving the targeted outcomes (primary: fatigue; secondary: depressive symptoms) as compared to the attention control (AC). II. To explore potential mediators (psychological stress, circadian disruption, inflammation) and moderators (gender, dose of the YST, outcome expectancies) of the effects of the YST on targeted outcomes. III. To qualitatively assess perceived efficacy of the interventions and acceptance of daily measurement through semi-structured interviews in a subset of participants. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (YST intervention): Patients undergo YST intervention comprising four individualized, 30 minute in-person sessions that instructs skills to enhance mindfulness and promote relaxation during outpatient chemotherapy sessions in weeks 2, 4, 6, and 8. Patients practice awareness - noticing the current state and establishing relaxed breathing for 5 minutes; movement - 7 minutes of gentle movements coordinated with the breath (such as raising and lowering the arms); breathing practice - 3 minutes of inhaling cool air as if through a straw; and meditation - 5 minutes of focus on letting go of physical and mental tension. Patients are given a handout describing the YST and audio recording with devices to play the recording to encourage patients to practice daily. Strategies to increase adherence to home practice will be implemented and patients will be asked to keep home practice logs. ARM II (attention control): Patients attend four 30-minute in-person sessions with an interventionist in weeks 2, 4, 6, and 8. During these sessions, patients are encouraged to discuss their experiences while receiving chemotherapy and do not receive instruction of movement, meditation or breathing practices. Patients will also be asked to write brief diary entries daily at home. After completion of study, patients are followed up for 4 weeks.
Conditions
- Depressive Symptoms
- Fatigue
- Psychosocial Effects of Cancer and Its Treatment
- Stage IIA Colon Cancer
- Stage IIA Rectal Cancer
- Stage IIB Colon Cancer
- Stage IIB Rectal Cancer
- Stage IIC Colon Cancer
- Stage IIC Rectal Cancer
- Stage IIIA Colon Cancer
- Stage IIIA Rectal Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIC Rectal Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Yoga Skills Training (YST) | Undergo YST |
| OTHER | questionnaire administration | Ancillary studies |
| OTHER | fatigue and depressive symptom assessment and management | Ancillary studies |
| OTHER | psychological stress assessment | Ancillary studies |
| OTHER | laboratory biomarker analysis | Correlative studies |
| OTHER | Attention Control |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-05-28
- Last updated
- 2015-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02148406. Inclusion in this directory is not an endorsement.